trazodone has been researched along with oxidopamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, ML; Fuller, RW; Snoddy, HD | 1 |
| Doherty, P; Duty, S; Fletcher, EJR; Jamieson, AD; Williams, G | 1 |
2 other study(ies) available for trazodone and oxidopamine
| Article | Year |
|---|---|
Interactions of trazodone with serotonin neurons and receptors.
Topics: 5-Hydroxytryptophan; Animals; Brain Chemistry; Hydroxydopamines; Male; Mice; Muscle, Smooth; Neurons; Norepinephrine; Oxidopamine; p-Chloroamphetamine; Piperazines; Quipazine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Trazodone | 1984 |
Targeted repositioning identifies drugs that increase fibroblast growth factor 20 production and protect against 6-hydroxydopamine-induced nigral cell loss in rats.
Topics: Albuterol; Animals; Brain; Computer Simulation; Corpus Striatum; Dimethadione; Dopaminergic Neurons; Drug Repositioning; Female; Fibroblast Growth Factors; Humans; MCF-7 Cells; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Salicylates; Substantia Nigra; Trazodone; Treatment Outcome | 2019 |